PublizoomAward notice Supplies
261A000098 - C.Central Medicamentos 2026 - 2026/0312 (-BEVACIzumab )
Notice published in Portuguese. The AI analysis summarises it for you in your language.
- Public buyer
- Unidade Local de Saúde Santa Maria, E.P.E.
Lisboa - Place of performance
- Lisboa
- Estimated value
- €71,125 excl. VAT
- Amount awarded
- €71,125 excl. VAT
- Planned end of contract
- 30 December 2026
likely re-tender around October 2026 - Bids received
- 1
- Procedure
- Open procedure
Any company may submit a bid. - Publication
- 13 July 2026
- Notice language
- Portuguese
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
C.Central Medicamentos 2026 - 2026/0312 (-BEVACIzumab )
Awarded to
2 lots
- Lote 1 - BEVACIzumab 100MG
- Lote 2 - BEVACIzumab 400MG
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33651500
Winning prices for comparable contracts
- A quarter below
- €58,860
- Median
- €71,125
- A quarter above
- €382,013
Amounts awarded (excl. VAT) over the last 3 years for 5 contracts in the same CPV group (3365…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| 261A000098 - C.Central Medicamentos 2026 - 2026/0312 Unidade Local de Saúde Santa Maria, E.P.E. · 10 August 2026 |
ACCORD HEALTHCARE UNIPESSOAL LDA | €58,860 |
| 261A000098 - C.Central Medicamentos 2026 - 2026/0312 - ECULIzumab Unidade Local de Saúde Santa Maria, E.P.E. · 10 August 2026 |
SAMSUNG BIOEPIS NL B. V | €382,013 |
| 261A000098 - C.Central Medicamentos 2026 - 2026/0312 - ECULIzumab Unidade Local de Saúde Santa Maria, E.P.E. · 10 August 2026 |
SAMSUNG BIOEPIS NL B. V | €382,013 |
| 261A000098 - C.Central Medicamentos 2026 - 2026/0312 (-BEVACIzumab ) Unidade Local de Saúde Santa Maria, E.P.E. · 13 July 2026 |
Cencora 3PL Portugal | €47,394 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 482465-2026.